The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

The incidence of prostate cancer is increasing, with most diagnosed with localized disease. Appropriate staging is crucial to ensure optimal treatments are delivered.

In this activity participants will learn how MR-guided radiation therapy impacts patient-reported outcomes in patients with prostate cancer.

Conventionally fractionated external beam radiation therapy (EBRT) has a long-standing track record of safety and excellent treatment outcomes in the management of all prostate cancer risk groups.

This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a business fundamentals review and a radiopharmaceuticals overview.

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

Improvements in technique, as well as advances in technology, have resulted in significant survival advances for those with localized and oligometastatic prostate cancer.

There have been many advancements in terms of treatment and imaging modalities for patients with oligometastatic prostate cancer. Failure to understand these advancements in treatment options leads to lower quality of care delivered by clinicians treating prostate cancer patients.

The use of SABR is well established in many cancers, however, its application within kidney cancer is relatively new. This is largely due to the historical notion that renal cell carcinoma (RCC) is highly radioresistant.

Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.